p53-independent tumor growth and in vitro cell survival for F-MuLV- induced erythroleukemias

Cell Growth and Differentiation

Volumn 7, Issue 12, 1996, Pages 1651-1660

  Howard, Jeff ^b   Ung, Yee ^b   Adachi, Dena ^b   Ben David, Yaacov ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROLINE; PROTEIN P53;

ANIMAL CELL; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL IMMORTALIZATION; CELL SURVIVAL; CHROMOSOME ABERRATION; CONTROLLED STUDY; ERYTHROLEUKEMIA; ETIOLOGY; FRIEND LEUKEMIA VIRUS; GENE MUTATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; TRANSGENIC ANIMAL; TUMOR GROWTH; TUMOR SUPPRESSOR GENE;

ANIMALS; APOPTOSIS; CELL DIVISION; CELL SURVIVAL; FRIEND MURINE LEUKEMIA VIRUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; KARYOTYPING; LEUKEMIA, ERYTHROBLASTIC, ACUTE; LEUKEMIA, EXPERIMENTAL; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; ORGAN SIZE; RETROVIRIDAE INFECTIONS; SPLEEN; TRANSGENES; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR VIRUS INFECTIONS;

ANIMALIA; FRIEND MURINE LEUKEMIA VIRUS; MURINAE; MURINE LEUKEMIA VIRUS; MUS MUSCULUS;

EID: 0029805002     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Ben-David, Y., and Bernstein, A. Friend virus-induced erythroleukemia and the multistage nature of cancer. Cell, 66: 831-834, 1991.
2. Kabat, D. Molecular biology of Friend viral erythroleukemia. Curr. Top. Microbiol. Immunol., 148: 1-42, 1990.
3. Silver, J., and Fredrickson, T. N. A new gene that controls the type of leukemia induced by Friend murine leukemia virus. J. Exp. Med., 158: 493-505, 1983.
4. Ben-David, Y., Giddens, E. B., and Bernstein, A. Identification and mapping of a common proviral integration site Fli-1 in erythroleukemia cells induced by Friend murine leukemia virus. Proc. Natl. Acad. Sci. USA, 87: 1332-1336, 1990.
5. Moreau-Gachelin, F., Tavitian, A., and Tambourin, P. Spi-1 is a putative oncogene in virally induced murine erythroleukemias. Nature (Lond.), 331: 277-280, 1938.
6. Moreau-Gachelin, F., Ray, D., de Both, N. J., van der Feltz, M. J. M., Tambourin, P., and Tavitian, A. Spi-1 oncogene activated in Rauscher and Friend murine virus-induced acute erythroleukemias. Leukemia (Baltimore), 4: 20-23, 1990.
7. Ben-David, Y., Giddens, E. G., Letwin, K., and Bernstein, A. Erythroleukemia induction by Friend murine leukemia virus: insertional activation of a new member of the ets gene family, Fli-1, closely linked to c-ets-1. Genes Dev. 5: 908-918, 1981.
8. Gobel, M. G., Moreau-Gachelin, F., Ray, D., Tambourin, P., Tavitian, A., Klemsz, M. J., McKercher, S. C., Van Beveren, C., and Maki, R. A. The PU.1 transcription factor is the product of the putative oncogene Spi-1. Cell, 61: 1165-1166, 1990.
9. Howard, J. C., Yousefi, S., Cheong, G., Bernstein, A., and Ben-David, Y. Temporal order and functional analysis of mutations within the Fli-1 and p53 genes during the erythroleukemias induced by F-MuLV. Oncogene, 8: 2721-2729, 1993.
10. Howard, J. C., Berger, L., Bani, M. R., Hawley, R., and Ben-David, Y. Activation of the erythropoietin gene in the majority of F-MuLV-induced erythroleukemias results in growth factor independence and enhanced tumorigenicity. Oncogene, 12: 1405-1415, 1996.
11. Mowat, M., Cheng, A., Kimura, N., Bernstein, A., and Benchimol, S. Rearrangements of the cellular p53 gene in erythroleukemic cells transformed by Friend virus. Nature (Lond.), 314: 633-636, 1985.
12. Johnson, P., Chung, S., and Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol., 13: 1456-1463, 1993.
13. 1 and S phase of the cell cycle without growth arrest or stabilization of wild-type p53. Mol. Cell. Biol., 14: 4183-4192, 1994.
14. Ryan, J. J., Danish, R., Gottlieb, C., and Clarke, M. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol. Cell. Biol., 13: 711-719, 1993.
15. Lavigueur, A., Maltby, V., Mock, D., Rossant, J., Pawson, T., and Bernstein, A. High incidence of lung, bone, and lymphoid tumors in transgenic mice overexpressing mutant alleles of the p53 oncogene. Mol. Cell. Biol., 9: 3982-3991, 1989.
16. Lavigueur, A., and Bernstein, A. p53 transgenic mice: accelerated erythroleukemia induction by Friend virus. Oncogene, 6: 2197-2201, 1991.
17. Mager, D., MacDonald, M. E., Robson, I. B., Mak, T. W., and Bernstein, A. Clonal analysis of the late stages of erythroleukemia induced by two distinct strains of Friend leukemia virus. Mol. Cell. Biol., 1: 721-730, 1981.
18. Miller, D. A., Tantravahi, R., Newman, B., Vaithilingam, G. D., and Miller, O. J. Karyotype of Friend virus-induced mouse erythroleukemia cells. Cytogenetics (Basel), 1: 103-113, 1979.
19. Ostertag, W., Melderis, H., Steinheider, G., Kluge, N., and Dube, S. Synthesis of mouse haemoglobin and globin mRNA in leukemic cell cultures. New Biol., 239: 231-234, 1972.
20. Preisler, H. D., Shiraishi, Y., Mori, M., and Sandberg, A. A. Clones of Friend leukemia cells: differences in karyotypes and responsiveness to inducers of differentiation. Cell Differ., 5: 207-216, 1976.
21. Munroe, D. G., Peacock, J. W., and Benchimol, S. Inactivation of the cellular p53 gene is a common feature of Friend erythroleukemia: relation to dominant transforming alleles. Mol. Cell. Biol., 10: 3307-3313, 1990.
22. Rovinski, B., and Benchimol, S. Immortalization of rat embryo fibroblasts by the cellular p53 oncogene. Oncogene, 2: 445-452, 1988.
23. Haupt, Y., Alexander, W. S., Barri, G., Klinken, S. P., and Adams, J. M. Novel zinc finger gene implicated as myc collaborator by retrovirally accelerated lymphomagenesis in Eu-myc transgenic mice. Cell, 65: 753- 763, 1991.
24. Schackleford, G. M., MacArthur, C. A., Kwan, H. C., and Varmus, H. E. Mouse mammary tumor virus infection accelerates mammary carcinogenesis in Wnt-1 transgenic mice by insertional activation of int-1/Fgf-3 and hst/Fgf-4. Proc. Natl. Acad. Sci. USA, 90: 740-744, 1993.
25. van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., and Berns, A. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell, 56: 673-682, 1989.
26. van Lohuizen, M., Verbeek, S., Sceijen, B., Wientjens, E., van der Gulden, H., and Berns, A. Identification of cooperating oncogenes in Eu-myc transgenic mice by provirus tagging. Cell, 65: 737-752, 1991.
27. Canman, C. E., Gilmer, T. M., Coutts, S. B., and Kastan, M. B. Growth factor modulation of p53-mediated growth arrest versus apoptosis. Genes Dev., 9: 600-611, 1995.
28. Haupt, Y., Rowan, S., Shaulian, E., Vousden, K. H., and Oren, M. Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev., 9: 2170-2183, 1995.
29. Sabbatini, P., Lin, J., Levine, A. J., and White, E. Essential role for p53-mediated transcription in E1A-induced apoptosis. Genes Dev., 9: 2184-2192, 1995.
30. Soddu, S., Blandino, G., Scardigli, R., Martinelli, R., Rizzo, M. G., Crescenzi, M., and Sacchi, A. Wild-type p53 induces diverse effects in 32D cells expressing different oncogenes. Mol. Cell. Biol., 16: 487-495, 1996.
31. Zhang, Y., Jiang, W., Chen, C. J., Lee, C. S., Kahn, S. M., Santella, R. M., and Weinstein, I. B. Amplification and overexpression of cyclin D1 in human hepatocellular carcinoma. Biochem. Biophys. Res. Comm., 196: 1010-1016, 1993.
32. Schuetze, S., Stenberg, P. E., and Kabat, D. The ets-related transcription factor PU.1 immortalizes erythroblasts. Mol. Cell. Biol., 13: 5670-5678, 1993.
33. Nibbs, R. J. B., Itoh, K., Ostertag, W., and Harrison, P. R. Differentiation arrest and stromal cell-independent growth of murine erythroleukemia cells are associated with elevated expression of ets-related genes but not with mutation of p53. Mol. Cell. Biol., 13: 5582-5592, 1993.
34. Raycroft, L., Wu, H., and Lozano, G. Transcriptional activation by wild-type but not transforming mutants of p53 anti-oncogene. Science, 249: 1049-1051, 1990.
35. Gu, Y., Turch, C. W., and Morgan, D. O. Inhibition of CDK2 activity in vivo by an associated 20K regulatory subunit. Nature (Lond.), 366: 707- 710, 1993.
36. Harper, J. W., Adami, G. R., Wei, N., Keyomarsi, K., and Elledge, S. J. The p21 cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin- dependent kinases. Cell, 75: 805-816, 1993.
37. Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., and Beach, D. P21 is a universal inhibitor of cyclin kinases. Nature (Lond.), 366: 701-704, 1993.
38. Kastan, M. B., Zhan, Q., El-Deiry, W. S., Carrier, F., Jacks, T., Walsh, W. V., Plunkett, B. S., Vogelstein, B., and Fornace, A. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxiatelangiectasia. Cell, 71: 587-597, 1992.
39. Kuerbitz, S. J., Plunkett, B. S., Walsh, W. V., and Kastan, M. B. Wild-type p53 is a cell cycle checkpoint determinant following irradiation. Proc. Natl. Acad. Sci. USA, 89: 7491-7495, 1992.
40. Livingstone, L. R., White, A., Sprouse, J., Livanos, E., Jacks, T., and Tlsty, T. D. Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53. Cell, 70: 923-935, 1992.
41. Yin, Y., Tainsky, M. A., Bischoff, F. Z., Strong, L. C., and Wahl, G. M. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles. Cell, 70: 937-948, 1992.
42. Blount, P. L., Meltzer, S. J., Yin, J., Huang, Y., and Krasna, M. J. Clonal ordering of 17p and 5q allelic losses in Barrett dysplasia and adenocarcinoma. Proc. Natl. Acad. Sci. USA, 90: 3221-3225, 1993.
43. Donehower, L. A., Godley, L. A., Aldaz, C. M., Pyle, R., Shi, Y., Pinkel, D., Gray, J., Bradley, A., Medina, D., and Varmus, H. E. Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability. Genes Dev., 882, 1995.
44. Metz, T., Harris, A. W., and Adams, J. M. Absence of p53 allows direct immortalization of hematopoietic cells by the myc and raf oncogenes. Cell, 82: 29-36, 1995.
45. Ben-David, Y., Lavigueur, A., Cheong, G. Y., and Bernstein, A. Insertional inactivation of the p53 gene during Friend leukemia: a new strategy for identifying tumor suppressor genes. New Biol., 2: 1015-1023, 1990.
46. Oliff, A., Oliff, I., Schmidt, B., and Famulari, N. Isolation of immortal cell lines from the first stage of murine leukemia virus-induced leukemia. Proc. Natl. Acad. Sci. USA, 81: 5464-5467, 1984.
47. Shibuya, T., and Mak, T. Isolation and induction of erythroleukemic cell lines with properties of erythroid progenitor burst-forming cell (BFU-E) and erythroid precursor cell (CFU-E). Proc. Natl. Acad. Sci. USA, 80: 3721-3725, 1983.
48. Gross-Bellard, M., Oudet, P., and Chambon, P. Isolation of high molecular weight DMA from mammalian cells. Eur. J. Biochem., 36: 32-38, 1973.
49. Jenkins, J. R., Rudge, K., Redomond, S., and Wade-Evans, A. Cloning and expression analysis of full length mouse cDNA sequences encoding the transformation associated protein p53. Nucleic Acids Res., 12: 5609-5626, 1984.
50. Marin, M. C., Hsu, B., Meyn, R. E., Donehower, L. A., el-Naggar, A. K., and McDonnell, T. J. Evidence that p53 and bcl-2 are regulators of a common cell death pathway important for in vivo lymphomagenesis. Oncogene, 9: 3107-3112, 1994.